Autologous dendritic cell immunotherapy

A form of therapy where a patient receives immune cells to fight cancer. Autologous refers to the fact that the cells are derived from the patient’s own blood. A dendritic cell is a specific immune cell that teaches a patient’s immune system to fight a specific disease, including cancer. This is done by first deriving dendritic cells from the patient’s blood. The dendritic cells are then engineered to display a specific “message” on their surface commonly called an “antigen” that is associated with cancer, (Asterias uses an antigen composed of a telomerase molecule). The dendritic cells teach the patient’s immune system to recognize the telomerase on the cancer cells and instruct the patient’s immune system to fight their cancer. This process results in helping the patient’s own immune system fight their cancer.